177 related articles for article (PubMed ID: 21365324)
1. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma.
Liu YF; Zhang PF; Li MY; Li QQ; Chen ZC
Clin Exp Metastasis; 2011 Jun; 28(5):413-25. PubMed ID: 21365324
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of annexin II expression in non-small cell lung cancer.
Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma.
Liu YF; Chen YH; Li MY; Zhang PF; Peng F; Li GQ; Xiao ZQ; Chen ZC
Med Oncol; 2012 Mar; 29(1):174-84. PubMed ID: 21132403
[TBL] [Abstract][Full Text] [Related]
5. Identification of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS combined with iTRAQ technology.
Zhang PF; Zeng GQ; Yi LZ; Liu JP; Wan XX; Qu JQ; Li JH; Li C; Tang CE; Hu R; Ye X; Chen Y; Chen ZC; Xiao ZQ
Oncol Rep; 2013 Jul; 30(1):341-9. PubMed ID: 23677397
[TBL] [Abstract][Full Text] [Related]
6. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
[TBL] [Abstract][Full Text] [Related]
7. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
Biaoxue R; Xiguang C; Hua L; Tian F; Wenlong G
Int J Biol Markers; 2017 Mar; 32(1):e132-e140. PubMed ID: 28009433
[TBL] [Abstract][Full Text] [Related]
8. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
9. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma.
Chen CY; Shen JQ; Wang F; Wan R; Wang XP
Asian Pac J Cancer Prev; 2012; 13(9):4707-12. PubMed ID: 23167407
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.
Hsu CH; Hsu CW; Hsueh C; Wang CL; Wu YC; Wu CC; Liu CC; Yu JS; Chang YS; Yu CJ
Mol Cell Proteomics; 2016 Jul; 15(7):2396-410. PubMed ID: 27161446
[TBL] [Abstract][Full Text] [Related]
12. Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.
Antonângelo L; Tuma T; Fabro A; Acencio M; Terra R; Parra E; Vargas F; Takagaki T; Capelozzi V
Exp Biol Med (Maywood); 2016 Jun; 241(11):1159-68. PubMed ID: 26869608
[TBL] [Abstract][Full Text] [Related]
13. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
14. [Hypoxia upregulates the expression of annexin A1 in lung adenocarcinoma a549 cells].
Hu Z; Huang J; Li Z; Li X; Fu Z; Liu H; Guan L
Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):277-80. PubMed ID: 22613333
[TBL] [Abstract][Full Text] [Related]
15. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
[TBL] [Abstract][Full Text] [Related]
16. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
Luo HT; Liang CX; Luo RC; Gu WG
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
[TBL] [Abstract][Full Text] [Related]
17. Role of Annexin A1 in Squamous Cell Lung Cancer Progression.
Elakad O; Li Y; Gieser N; Yao S; Küffer S; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Ströbel P; Bohnenberger H
Dis Markers; 2021; 2021():5520832. PubMed ID: 33959206
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients.
Biaoxue R; Xiling J; Shuanying Y; Wei Z; Xiguang C; Jinsui W; Min Z
J Exp Clin Cancer Res; 2012 Aug; 31(1):70. PubMed ID: 22929401
[TBL] [Abstract][Full Text] [Related]
19. Co-overexpression of Hsp90-β and annexin A1 with a significantly positive correlation contributes to the diagnosis of lung cancer.
Biaoxue R; Shuanying Y; Wei L; Zongjuan M; Xiguang C; Qiuhong Z
Expert Rev Mol Diagn; 2014 Nov; 14(8):1067-79. PubMed ID: 25300907
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ
Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
